Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis.
Puro V, De Carli G, Orchi N, Palvarini L, Chiodera A, Fantoni M, Del Borgo C, Iemoli E, Niero F, Monti M, Micheloni G, Caggese L, Lodesani C, Raineri G, Massari M, Drenaggi D, Ippolito G; Italian Registry of Antiretroviral Post-Exposure Prophylaxis. Puro V, et al. Among authors: iemoli e. J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):238-42. J Biol Regul Homeost Agents. 2001. PMID: 11693431
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Characteristics of patients with allergic polysensitization: the POLISMAIL study.
Ciprandi G, Alesina R, Ariano R, Aurnia P, Borrelli P, Cadario G, Capristo A, Carosso A, Casino G, Castiglioni G, Cesinaro Di Rocco P, Colangelolo C, Di Gioacchino M, Di Paola MG, Errico G, Fiorina A, Gambuzza F, Gangemi S, Gasparini A, Giugno R, Iemoli E, Isola S, Maniero G, Marengo F, Mazzali P, Minelli M, Mosca M, Pellegrino R, Piconi S, Pravettoni V, Quaglio L, Ricciardi L, Ridolo E, Sillano V, Valle C, Varin E, Verini M, Zambito M, Riario-Sforza GG, Incorvaia C, Puccinelli P, Scurati S, Frati F. Ciprandi G, et al. Among authors: iemoli e. Eur Ann Allergy Clin Immunol. 2008 Nov;40(3):77-83. Eur Ann Allergy Clin Immunol. 2008. PMID: 19334371
39 results